Vitamin C Pricing In Supreme Court, Vitamin D QHC Petition Fails: Health And Wellness Industry News
This article was originally published in The Rose Sheet
Supreme Court will hear an appeal of a circuit court's reversal of a ruling that two vitamin C importers violated US antitrust laws by conspiring to fix prices; Bayer request for vitamin D QHC for multiple sclerosis rejected; Inno-Vita warned on cleansing drug claims; and 'Prevention' clear in ABC-AHP-NCNPR program name.
You may also be interested in...
Supreme Court Vitamin C Price-Fixing Decision Could Juice Litigation Against Foreign Businesses Broadly
US businesses in any industry could use the Supreme Court's ruling that federal courts have leeway in whether to recognize a foreign country's laws as applicable in a firm's defense against unfair business practices and similar civil complaints, say attorneys tracking class-action litigation vitamin C marketers Animal Science Products and Ranis Co. filed against multiple Chinese firms supplying the ingredient.
PD-1/PDL-1 inhibitors have not proved effective for ovarian cancer on their own or in combinations. Now Roche's Tecentriq, combined with the firm's blockbuster Avastin, has suffered a similar fate to Merck KGaA and Pfizer's Bavencio in failing to improve survival.
Increased uptake for generics and biosimilars must become Belgium’s “new normal” in the wake of the coronavirus crisis, local off-patent industry association Medaxes has argued.